Session Details

S042 Coding and Documentation

Sun, Mar 29, 1:00 PM - 4:00 PM
Mile High 3A
3 CME Available Symposium ARS Practice Management Upcoming
View Map

DESCRIPTION

Speakers in this session review key elements of coding and documentation relevant to the day-to-day practice of clinical dermatologists. Recent or imminent changes in rules and regulations are highlighted. Adequate time is available for numerous questions from the audience.

LEARNING OBJECTIVES

1.

Code E/M visits and procedures correctly.

2.

Apply current rules and guidelines to ensure that chart documentation accurately conveys what occurred and is also adequate to support the codes selected.

3.

Describe recent and impending changes in coding and documentation guidelines.

SCHEDULE

1:00 PM

Proving Medical Necessity: Essential Documentation for Mohs Surgery

Alexander Miller, MD, FAAD

1:30 PM

Don’t Get Burned: Audit Readiness and Defending Your Dermatology Claims

Faith McNicholas

2:00 PM

Teledermatology Coding in 2026 and Beyond: What’s Staying, What’s Changing

Trilokraj Tejasvi, MD, MBBS

2:30 PM

E/M Made Practical: Documenting to Support Payment

Alexandra Flamm, MD, FAAD

3:00 PM

Beyond the Graft: Mastering Documentation and Coding for Skin Substitutes

3:30 PM

Coding Updates for 2026: Updates Every Dermatologist Should Know

DIRECTOR

Alexander Miller, MD, FAAD

Alexander Miller, MD, FAAD

SPEAKERS

Alexandra Flamm, MD, FAAD

Alexandra Flamm, MD, FAAD

David T. Harvey, MD, FAAD

David T. Harvey, MD, FAAD

Faith McNicholas

Faith McNicholas

Howard Wooding Rogers, MD, PhD, FAAD

Howard Wooding Rogers, MD, PhD, FAAD

Trilokraj Tejasvi, MD, MBBS

Trilokraj Tejasvi, MD, MBBS

DISCLOSURES

Alexandra Flamm, MD, FAAD

No financial relationships exist with ineligible companies.

David T. Harvey, MD, FAAD

No financial relationships exist with ineligible companies.

Faith McNicholas

No financial relationships exist with ineligible companies.

Alexander Miller, MD, FAAD

No financial relationships exist with ineligible companies.

Howard Wooding Rogers, MD, PhD, FAAD

Biofrontera AG – Consultant (1099 relationship)(Fees);

Trilokraj Tejasvi, MD, MBBS

No financial relationships exist with ineligible companies.